SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-21-000065
Filing Date
2021-11-15
Accepted
2021-11-15 08:08:51
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20211115.htm   iXBRL 8-K 32819
2 EX-99.1 pressrelease11152021.htm EX-99.1 238505
  Complete submission text file 0001510964-21-000065.txt   412036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20211115.xsd EX-101.SCH 1933
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20211115_lab.xml EX-101.LAB 21488
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20211115_pre.xml EX-101.PRE 11112
6 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20211115_htm.xml XML 9105
Mailing Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121
Business Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 211406496
SIC: 2834 Pharmaceutical Preparations